1. Home
  2. FICO vs ONC Comparison

FICO vs ONC Comparison

Compare FICO & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fair Isaac Corproation

FICO

Fair Isaac Corproation

N/A

Current Price

$1,176.32

Market Cap

34.7B

ML Signal

N/A

ONC

BeiGene Ltd. American Depositary Shares

N/A

Current Price

$299.25

Market Cap

33.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FICO
ONC
Founded
1956
2010
Country
United States
Switzerland
Employees
N/A
12000
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.7B
33.5B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
FICO
ONC
Price
$1,176.32
$299.25
Analyst Decision
Buy
Strong Buy
Analyst Count
12
10
Target Price
$1,985.25
$386.70
AVG Volume (30 Days)
228.4K
224.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.78
N/A
EPS
6.61
N/A
Revenue
$1,032,475,000.00
N/A
Revenue This Year
$27.68
$759.19
Revenue Next Year
$17.15
$14.51
P/E Ratio
$194.48
$614.06
Revenue Growth
N/A
N/A
52 Week Low
$1,193.10
$196.53
52 Week High
$2,217.60
$385.22

Technical Indicators

Market Signals
Indicator
FICO
ONC
Relative Strength Index (RSI) 29.89 34.83
Support Level N/A $292.79
Resistance Level $1,829.71 $300.00
Average True Range (ATR) 64.25 9.26
MACD -4.22 -4.32
Stochastic Oscillator 8.00 11.65

Price Performance

Historical Comparison
FICO
ONC

About FICO Fair Isaac Corproation

Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: